Evidence based development and challenge of laboratory examination of thrombosis
10.3760/cma.j.issn.1009-9158.2017.04.024
- VernacularTitle:血栓实验室检查的循证发展与挑战
- Author:
Jianlong MEN
;
Zhenguo ZHAI
- Keywords:
Thrombosis;
Blood coagulation tests;
Platelet aggregation;
Evidence-based medicine
- From:
Chinese Journal of Laboratory Medicine
2017;40(4):331-334
- CountryChina
- Language:Chinese
-
Abstract:
The clinical application of the laboratory examination with thrombosis can be divided into four categories,including risk assessment,diagnosis by exclusion,auxiliary diagnosis and therapic monitoring.Theevidence based parameters which subsumed into the international guidelines of thrombosis related clinical management,included the prothrombin time,activited partial thomboplastin time,anti-factor X a activity,D-dimer,coagulation factor Ⅷ,naturally occurring anticoagulants,antiphospholipid syndromeassociative parameters,heparin induced thrombocytopenia antibodies and platelet aggregation test,which provided the important evidence for clinical intervention and establishment of antithrombotic strategy.Theother thrombosis tests are still lack of sufficient evidence,therefore we need to participate in multicentric clinical randomized controlled study actively,and implementing the systematic review and meta-analysis forwardly,solving clinical questions based on PICO (Patients,Intervention,Comparision,Outcome),promoting the clinical application of laboratory parameters.
